Disparities Persist in Guideline-Concordant Care for Pancreatic Cancer

Research finds stark disparities in treatment and survival time for people with pancreatic cancer

New research appearing in JNCCN—Journal of the National Comprehensive Cancer Network found significant disparities based on race, socioeconomic status, and other factors when it came to quality of care and outcomes for people with metastatic pancreatic adenocarcinoma (mPDAC)—which is associated with very high cancer mortality.

Disparities Persist in Guideline-Concordant Care for Pancreatic Cancer

(MedPage Today) -- While the vast majority of patients with metastatic pancreatic ductal adenocarcinoma (PDAC) receive at least one aspect of guideline-concordant care -- with that proportion steadily increasing -- disparities still persist...

Pancreatic Cancer Care Varies with Race and Socioeconomic Status

The care pancreatic cancer patients receive may depend a lot on their race, socioeconomic status, and other factors, a new study finds. “The results highlight the need for targeted interventions to mitigate disparities in cancer care,” said co-author Diamantis Tsilimigras, MD, PhD, of The Ohio State University Wexner Medical Center and James Comprehensive Cancer Center.   He added, “Federal policies that expand Medicaid or possibly expand Medica…

Equity in Biomedicine past talks

Equity in Biomedicine past talks By Rose Circeo April 9, 2025 Breadcrumb Home For Scientists Equity in Biomedicine past talks 2024 Fireside Chat - Racial Disparities in Cancer Research and Outcomes October 10, 2024 Join Equity in Biomedicine and Women At Broad for a fireside chat between Dr. Nyasha Chambwe and our very own Dr. Alicia Martin to discuss Racial Disparities in Cancer Research and Outcomes. Dr. Chambwe’s work focuses on under…

NCCN Data Find Racial, Socioeconomic Disparities in Quality of Care for Metastatic Pancreatic Cancer

New data from the National Comprehensive Cancer Network (NCCN) reveal that socially vulnerable and minority patients with metastatic pancreatic cancer are less likely to receive recommended treatments and achieve longer survival.